Desmoid tumor other diagnostic studies

Desmoid tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Desmoid tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Immunohistochemical staining of spindle cells of desmoid tumors are positive for nuclear beta-catenin, vimentin, alpha smooth muscle actin, muscle actin and negative for desmin, cytokeratins, and S-100. Antibodies like smooth muscle actin, desmin and KIT may be helpful in distinguishing desmoid tumors from other tumors. In addition, APC germline mutations may be performed in patients with sporadic desmoid tumors with no clinical or famililal signs of FAP but having a family history of colorectal carcinoma in at least one family member.

Other diagnostic studies

Characteristic features of desmoid tumors on immunohistochemistry and relevant antibodies

Other diagnostic tests	Associated characteristics features
Immunohistochemistry (aids histologic diagnosis)	Spindle cells on immunohistochemical stains show the following features: Positive for: Nuclear beta-catenin (regardless of the site, 90% of desmoids show nuclear reactivity, relatively high specificity) Vimentin Alpha smooth muscle actin Muscle actin Negative for: Desmin Cytokeratins S-100
Antibodies	In order to distinguish desmoid tumors from other tumors, following antibodies are often examined: Smooth muscle actin Desmin KIT
APC germline mutational analysis	Sporadic desmoid tumor patients with no clinical or familial signs of familial adenomatous polyposis (FAP) but having a family history of colorectal carcinoma in at least one family member